News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
WIRTH PETER
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/30/2023 |
4
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 18,903 shares
@ $26.45, valued at
$500k
|
|
| 06/02/2023 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 12/12/2022 |
4/A
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Bought 4,000 shares
@ $71.36, valued at
$285.4k
|
|
| 12/09/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Sold 3,852 shares
@ $35.37, valued at
$136.2k
Sold 4,000 shares
@ $35.33, valued at
$141.3k
|
|
| 10/14/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Forma Therapeutics Holdings, Inc.|
Txns:
| Unknown transaction of 127,665 shares
@ $0
Unknown transaction of 7,250 shares
@ $0
Disposed/sold 14,026 options to buy
@ $5.05, valued at
$70.8k
Disposed/sold 28,053 options to buy
@ $5.43, valued at
$152.3k
Disposed/sold 17,533 options to buy
@ $20, valued at
$350.7k
Disposed/sold 8,375 options to buy
@ $25.35, valued at
$212.3k
Disposed/sold 6,750 options to buy
@ $6.12, valued at
$41.3k
|
|
| 09/19/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 7,763 shares
@ $0 |
|
| 12/08/2021 |
4
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Bought 4,000 shares
@ $71.36, valued at
$285.4k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $6.3, valued at
$110.3k
|
|
| 01/20/2021 |
4
| WIRTH PETER (Director) has filed a Form 4 on Zai Lab Ltd|
Txns:
| Granted 3,852 shares
@ $0 |
|
| 01/19/2021 |
3/A
| WIRTH PETER (Director) has filed a Form 3/A on Zai Lab Ltd |
| 01/19/2021 |
3/A
| WIRTH PETER (Director) has filed a Form 3/A on Zai Lab Ltd |
| 01/04/2021 |
3
| WIRTH PETER (Director) has filed a Form 3 on Zai Lab Ltd |
| 06/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/11/2020 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $9.17, valued at
$160.5k
|
|
| 06/12/2019 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.6, valued at
$61.6k
|
|
| 06/15/2018 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 11,000 options to buy
@ $12.95, valued at
$142.5k
|
|
| 01/30/2017 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 01/30/2017 |
3
| WIRTH PETER (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 06/23/2015 |
4
| WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Disposed/sold 7,500 options to buy
@ $40.32, valued at
$302.4k
Disposed/sold 15,000 options to buy
@ $40.74, valued at
$611.1k
Disposed/sold 7,500 options to buy
@ $80.35, valued at
$602.6k
|
|
| 06/05/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/29/2012 |
4
| WIRTH PETER (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 15,000 options to buy
@ $40.74, valued at
$611.1k
|
|
| 06/29/2012 |
3
| WIRTH PETER (Director) has filed a Form 3 on SYNAGEVA BIOPHARMA CORP |
| 04/06/2011 |
4
| WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP|
Txns:
| Unknown transaction of 15,660 shares
@ $74, valued at
$1.2M
Disposed/sold 29,250 shares
@ $74, valued at
$2.2M
Unknown transaction of 148 shares
@ $74, valued at
$11k
Exercised 14,250 restricted stock units
@ $0
Exercised 15,000 restricted stock units
@ $0
Disposed/sold 42,750 options to buy
@ $51.52, valued at
$2.2M
Disposed/sold 42,750 options to buy
@ $58.66, valued at
$2.5M
Disposed/sold 45,000 options to buy
@ $68.48, valued at
$3.1M
Disposed/sold 45,000 options to buy
@ $62.16, valued at
$2.8M
Disposed/sold 69,000 options to buy
@ $58.5, valued at
$4M
Disposed/sold 69,000 options to buy
@ $62.98, valued at
$4.3M
|
|
| 06/18/2010 |
4
| WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP|
Txns:
| Granted 42,750 options to buy
@ $51.52, valued at
$2.2M
|
|
| 05/26/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2010 |
4
| WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP|
Txns:
| Sold 48,216 shares
@ $50.51, valued at
$2.4M
Exercised 48,216 options to buy
@ $26.5, valued at
$1.3M
|
|
| 05/26/2009 |
4
| WIRTH PETER (Exec VP,Legal & Corporate Dev.) has filed a Form 4 on GENZYME CORP |
|
|
|